PDS Biotechnology (NASDAQ:PDSB) filed to sell 9.82M shares of common stock for holders. This preliminary prospectus is not an offer to sell. Filing More on PDS Biotechnology PDS Biotech outlines ...

Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on ...

Allspring Common Stock Fund earns a Below Average Process Pillar rating. The process is strengthened by the experience of the management team, which averages 24 years at this fund. However ...

Insight Enterprises (NSIT) announced it has entered into a stock repurchase agreement with ValueAct Capital Master Fund to ...

Ryman Hospitality Properties (NYSE:RHP)  announced the upsizing and pricing of its underwritten registered public offering of ...

Live Updates Live Coverage Has Ended This Dial Goes to 5 4:18 pm The Vanguard S&P 500 ETF closed Friday at 546.26, up 0.6% ...

Unum Group (NYSE: UNM) announced today that its board of directors has authorized an increase of approximately 10 percent in ...

“ Grand Theft Auto ” publisher Take-Two Interactive is planning to sell off $1 billion of its common stock. In addition to ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, ...

Preferred stock combines aspects of both common stock and bonds in one security, including regular income and ownership in the company. Investors buy preferred stock to bolster their income and ...

Shares of MicroStrategy Inc. charged higher Monday, after the software company and bitcoin stockpiler said it sold off more of its stock to help fund the purchase of bitcoin, both at what ended up ...

Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on ...